ITMI921951A1 - Derivati imidazolici ad attivita' a ii antagonista - Google Patents

Derivati imidazolici ad attivita' a ii antagonista

Info

Publication number
ITMI921951A1
ITMI921951A1 IT001951A ITMI921951A ITMI921951A1 IT MI921951 A1 ITMI921951 A1 IT MI921951A1 IT 001951 A IT001951 A IT 001951A IT MI921951 A ITMI921951 A IT MI921951A IT MI921951 A1 ITMI921951 A1 IT MI921951A1
Authority
IT
Italy
Prior art keywords
antagonist
activity
imidazolic
derivatives
imidazolic derivatives
Prior art date
Application number
IT001951A
Other languages
English (en)
Inventor
Jacques Mizrahi
Fabio Paleari
Aldo Salimbeni
Carlo Scolastico
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of ITMI921951A0 publication Critical patent/ITMI921951A0/it
Priority to ITMI921951A priority Critical patent/IT1255802B/it
Priority to CA002141853A priority patent/CA2141853A1/en
Priority to PCT/EP1993/002024 priority patent/WO1994003449A1/en
Priority to US08/379,468 priority patent/US5587390A/en
Priority to DE69306792T priority patent/DE69306792T2/de
Priority to AU47041/93A priority patent/AU4704193A/en
Priority to EP93917692A priority patent/EP0654030B1/en
Priority to ES93917692T priority patent/ES2095662T3/es
Publication of ITMI921951A1 publication Critical patent/ITMI921951A1/it
Application granted granted Critical
Publication of IT1255802B publication Critical patent/IT1255802B/it
Priority to GR970400533T priority patent/GR3022858T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ITMI921951A 1992-08-07 1992-08-07 Derivati imidazolici ad attivita' a ii antagonista IT1255802B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI921951A IT1255802B (it) 1992-08-07 1992-08-07 Derivati imidazolici ad attivita' a ii antagonista
DE69306792T DE69306792T2 (de) 1992-08-07 1993-07-29 Imidazol-derivate mit angiotensin ii antagonistischer wirkung
PCT/EP1993/002024 WO1994003449A1 (en) 1992-08-07 1993-07-29 Imidazole derivatives having a ii antagonist activity
US08/379,468 US5587390A (en) 1992-08-07 1993-07-29 Imidazole derivatives having a II antagonist activity
CA002141853A CA2141853A1 (en) 1992-08-07 1993-07-29 Imidazole derivatives having a ii antagonist activity
AU47041/93A AU4704193A (en) 1992-08-07 1993-07-29 Imidazole derivatives having a ii antagonist activity
EP93917692A EP0654030B1 (en) 1992-08-07 1993-07-29 Imidazole derivatives having angiotensin ii antagonist activity
ES93917692T ES2095662T3 (es) 1992-08-07 1993-07-29 Derivados de imidazol con actividad antagonista de la angiotensina ii.
GR970400533T GR3022858T3 (en) 1992-08-07 1997-03-18 Imidazole derivatives having a ii antagonist activity.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921951A IT1255802B (it) 1992-08-07 1992-08-07 Derivati imidazolici ad attivita' a ii antagonista

Publications (3)

Publication Number Publication Date
ITMI921951A0 ITMI921951A0 (it) 1992-08-07
ITMI921951A1 true ITMI921951A1 (it) 1994-02-07
IT1255802B IT1255802B (it) 1995-11-16

Family

ID=11363850

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921951A IT1255802B (it) 1992-08-07 1992-08-07 Derivati imidazolici ad attivita' a ii antagonista

Country Status (9)

Country Link
US (1) US5587390A (it)
EP (1) EP0654030B1 (it)
AU (1) AU4704193A (it)
CA (1) CA2141853A1 (it)
DE (1) DE69306792T2 (it)
ES (1) ES2095662T3 (it)
GR (1) GR3022858T3 (it)
IT (1) IT1255802B (it)
WO (1) WO1994003449A1 (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224144D0 (en) * 1992-11-18 1993-01-06 Erba Carlo Spa Phenyl-imidazolidinone derivatives and process for their preparation
IT1273790B (it) * 1994-02-18 1997-07-10 Guidotti & C Spa Labor Derivati eterociclici diazotati aventi attivita' aii antagonista
JP2001509131A (ja) * 1996-04-03 2001-07-10 メルク エンド カンパニー インコーポレーテッド ファルネシルプロテイントランスフェラーゼの阻害剤
JP2000507590A (ja) * 1996-04-03 2000-06-20 メルク エンド カンパニー インコーポレーテッド ファルネシル―タンパク質トランスフェラーゼ阻害剤
US5854265A (en) * 1996-04-03 1998-12-29 Merck & Co., Inc. Biheteroaryl inhibitors of farnesyl-protein transferase
WO1997036890A1 (en) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5883105A (en) * 1996-04-03 1999-03-16 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO1997036898A1 (en) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2249665A1 (en) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP1386915A4 (en) * 2001-05-09 2004-11-10 Sumitomo Chem Takeda Agro Co AZOLE-LIKE COMPOUNDS, PROCESS FOR THE PREPARATION AND USE OF SAID COMPOUNDS
US7482366B2 (en) * 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
WO2007087283A2 (en) 2006-01-23 2007-08-02 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
EP2007757B1 (en) 2006-04-13 2012-10-03 Vertex Pharmceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
US7851495B2 (en) 2006-05-23 2010-12-14 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
US8853244B2 (en) 2006-05-23 2014-10-07 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
WO2008029825A1 (fr) 2006-09-05 2008-03-13 Kyowa Hakko Kirin Co., Ltd. Dérivé d'imidazole
CN101200455B (zh) * 2007-09-29 2010-08-18 泰兴市江神化工有限公司 沙坦类治疗高血压药物主环5-(4'-甲酰基联苯-2-基)-1h-四氮唑的制备方法
WO2011134019A1 (en) * 2010-04-30 2011-11-03 The University Of Melbourne Novel biphenyl sartans
CN102702117B (zh) * 2012-06-01 2016-04-13 浙江沙星医药化工有限公司 一种制备5-(4’-溴代甲基-2-联苯基)-1-三苯甲基四氮唑的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
DE69025473T2 (de) * 1989-06-30 1996-10-17 Du Pont Substituierte imidazole und ihre verwendung als hemmmstoff fur angiotensin ii
AU645022B2 (en) * 1989-06-30 1994-01-06 E.I. Du Pont De Nemours And Company Fused-ring aryl substituted imidazoles
US5126342A (en) * 1990-10-01 1992-06-30 Merck & Co., Inc. Imidazole angiotensin ii antagonists incorporating acidic functional groups
AT395853B (de) * 1991-01-31 1993-03-25 Chem Pharm Forsch Gmbh Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
IT1255802B (it) 1995-11-16
DE69306792T2 (de) 1997-05-07
US5587390A (en) 1996-12-24
AU4704193A (en) 1994-03-03
ES2095662T3 (es) 1997-02-16
EP0654030B1 (en) 1996-12-18
GR3022858T3 (en) 1997-06-30
CA2141853A1 (en) 1994-02-17
EP0654030A1 (en) 1995-05-24
DE69306792D1 (de) 1997-01-30
ITMI921951A0 (it) 1992-08-07
WO1994003449A1 (en) 1994-02-17

Similar Documents

Publication Publication Date Title
ITMI921951A1 (it) Derivati imidazolici ad attivita' a ii antagonista
ATA75293A (de) Indolderivate
DE69332484D1 (de) Rapamycinderivate
NO932146D0 (no) Benzimidazolderivater
DE69330497D1 (de) Chinazolin-derivate
ITMI912182A1 (it) Composti eterociclici ad attivita' a ii antagonista
DK0449079T3 (da) Hydantoinderivater
DE59308714D1 (de) Cyclobutan-benzol-derivate
NO952288D0 (no) Benzazepinon-derivater
FI941372A0 (fi) Järjestely puomia varten
ITMI921832A0 (it) Eteri di imidazoli ad attivita' a ii antagonista
DE69313890D1 (de) 5-Aminoflavon-Derivate
ITTO920114A1 (it) Derivati bis-tetrazolici ad attivita' antiallergica e citoprotettiva
ZA93144B (en) Substituted benzimidazole derivatives
DE69226786D1 (de) Kniegelenksorthese
ITMI921865A0 (it) Glicerofosfoderivati farmacologicamente attivi
DK136492D0 (da) A pharmaceutical formulation
ITMI911141A1 (it) Preparato ad attivita' anticellulitica
DE69224296D1 (de) Baumaschine
ITMI913432A1 (it) Derivati pirimidinici sostituiti da eteroarili ad attivita' a ii antagonista
ITMI920564A0 (it) Derivati idantoinici
ITMI920562A0 (it) Derivati idantoinici
BR9306706A (pt) Derivados do triazolil-butano
ITMI921863A0 (it) Derivati 1,4-benzotiazinici ad attivita' calcio antagonista
ITMI910596A0 (it) Gliceroderivati farmacologicamente attivi

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960826